Treatments

LPO (nmoles/mg protein)

CAT  (nmol/min/mg protein)

SOD  (units/mg protein)

GPx  (nmoles of GSH oxidized/min/mg protein)

Control

3.28±0.19a

312.2±14.3ab

18.8±0.80a

4.26±0.25a

GT

3.22±0.18a

324.4±9.4a

19.0±0.56a

4.19±0.24a

Cyr

4.92±0.15c

237.2±11.1de

12.0±0.90cd

2.95±0.09b

CPF

5.18±0.13c

214.8±7.1ef

12.2±0.94cd

2.80±0.07b

Cyr+CPF

5.87±0.21d

198.4±11.8f

10.3±0.84d

2.58±.09b

Cyr+GT

3.54±0.17a

280.8±14.9bc

14.3±0.67bc

3.89±0.19a

CPF+GT

3.68±0.17ab

265.6±11.8cd

15.3±0.77b

4.05±0.18a

Cyr+CPF +GT

4.05±0.14b

271.4±11.7cd

13.5±0.70bc

3.78±0.12a

Each value is a mean of 6 rats ± S.E.M; a, b, c, d values are not sharing superscripts letters (a, b, c, d) differ significantly at p < 0.05; Cyr: Cyromazine; CPF: Chlorpyrifos; GT: Green tea.
Table 2: Effect of cyromazine and/or chlorpyrifos on renal lipid peroxidation and antioxidant enzymes of male rats and the ameliorative role of green.